Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vietnam-Japan Cooperative Research on Prognosis of HIV-1-infection -Clinical Utility of Urinary beta2 Microglobulin as an Early Marker of Renal Dysfunction Caused by Use of Tenofovir in Vietnamese HIV-Infected Patients-

NCT02256579 is registered in ClinicalTrials.gov with National Center for Global Health and Medicine, Japan as lead sponsor.

NCT NCT02256579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02256579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vietnam-Japan Cooperative Research on Prognosis of HIV-1-infection -Clinical Utility of Urinary beta2 Microglobulin as an Early Marker of Renal Dysfunction Caused by Use of Tenofovir in Vietnamese HIV-Infected Patients-
Lead sponsor
National Center for Global Health and Medicine, Japan
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2014
Completion date
March 31, 2017
Enrollment
1,800 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection, renal function disorder, renal tubular disorder